SOMATOSTATIN IN ALZHEIMERS-DISEASE AND DEPRESSION

被引:70
作者
BISSETTE, G
MYERS, B
机构
关键词
D O I
10.1016/0024-3205(92)90534-V
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Somatostatin (somatotropin release-inhibiting factor, SRIF) was originally discovered(1) during the purification of growth hormone-releasing factor from rat hypothalamus and was subsequently isolated and characterized(2) in 1972 from ovine hypothalamus. Since its initial characterization, SRIF has been shown to fulfill criteria for a neurotransmitter and to directly modulate neuronal activity as well as acting as an inhibitory factor regulating endocrine and exocrine secretion. Alterations in cerebrospinal fluid (CSF) concentrations of SRIF have been reported in several diseases exhibiting prominent cognitive dysfunction, including Alzheimer's disease (AD), major depression, Huntington's chorea, multiple sclerosis, schizophrenia and Parkinson's disease, while evidence for regional brain tissue concentration deficits in SRIF are more specific for AD. This mini-review will focus on the studies reporting alterations in CSF and post-mortem mortem tissue concentrations of SRIF in AD and depression.
引用
收藏
页码:1389 / 1410
页数:22
相关论文
共 89 条
  • [1] LOW-LEVELS OF SOMATOSTATIN IN HUMAN CSF MARK DEPRESSIVE EPISODES
    AGREN, H
    LUNDQVIST, G
    [J]. PSYCHONEUROENDOCRINOLOGY, 1984, 9 (03) : 233 - 248
  • [2] SOMATOSTATIN AND COGNITIVE FUNCTIONS IN ALZHEIMERS-DISEASE - THE RELATIONSHIP OF CEREBROSPINAL-FLUID SOMATOSTATIN INCREASE WITH CLINICAL-RESPONSE TO TETRAHYDROAMINOACRIDINE
    ALHAINEN, K
    SIRVIO, J
    HELKALA, EL
    REINIKAINEN, K
    RIEKKINEN, P
    [J]. NEUROSCIENCE LETTERS, 1991, 130 (01) : 46 - 48
  • [3] EVIDENCE THAT SOMATOSTATIN ENHANCES ENDOGENOUS ACETYLCHOLINE-RELEASE IN THE RAT HIPPOCAMPUS
    ARAUJO, DM
    LAPCHAK, PA
    COLLIER, B
    QUIRION, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (05) : 1546 - 1555
  • [4] ARIA H, 1984, NEUROSCI LETT, V52, P73
  • [5] CEREBROSPINAL-FLUID SOMATOSTATIN AND NEUROPEPTIDE-Y - CONCENTRATIONS IN AGING AND IN DEMENTIA OF THE ALZHEIMER TYPE WITH AND WITHOUT EXTRAPYRAMIDAL SIGNS
    ATACK, JR
    BEAL, MF
    MAY, C
    KAYE, JA
    MAZUREK, MF
    KAY, AD
    RAPOPORT, SI
    [J]. ARCHIVES OF NEUROLOGY, 1988, 45 (03) : 269 - 274
  • [6] SOMATOSTATIN-281-12-LIKE IMMUNOREACTIVITY IS REDUCED IN ALZHEIMERS-DISEASE CEREBRAL-CORTEX
    BEAL, MF
    BENOIT, R
    MAZUREK, MF
    BIRD, ED
    MARTIN, JB
    [J]. BRAIN RESEARCH, 1986, 368 (02) : 380 - 383
  • [7] WIDESPREAD REDUCTION OF SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN THE CEREBRAL-CORTEX IN ALZHEIMERS-DISEASE
    BEAL, MF
    MAZUREK, MF
    SVENDSEN, CN
    BIRD, ED
    MARTIN, JB
    [J]. ANNALS OF NEUROLOGY, 1986, 20 (04) : 489 - 495
  • [8] BEAL MF, 1986, NEUROLOGY, V36, P273
  • [9] REDUCED NUMBERS OF SOMATOSTATIN RECEPTORS IN THE CEREBRAL-CORTEX IN ALZHEIMERS-DISEASE
    BEAL, MF
    MAZUREK, MF
    TRAN, VT
    CHATTHA, G
    BIRD, ED
    MARTIN, JB
    [J]. SCIENCE, 1985, 229 (4710) : 289 - 291
  • [10] BEAL MF, 1984, ALZHEIMERS DISEASE A, P229